[Provision of assistive devices in amyotrophic lateral sclerosis : Analysis of 3 years case management in an internet-based supply network].

CONCLUSION: Only two thirds of the medically indicated AD reached the patients. Rejection rates by patients and payers and latency of provision of care were high. The PAD can substantially vary among health insurance companies. The establishment of consented criteria for PAD and their integration into treatment regimens and guidelines are crucial tasks for the future. PMID: 26220007 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26220007?dopt=Abstract

Source: Der Nervenarzt - July 30, 2015 Category: Neurology Authors: Funke A, Grehl T, Großkreutz J, Münch C, Walter B, Kettemann D, Karnapp C, Gajewski N, Meyer R, Maier A, Gruhn KM, Prell T, Kollewe K, Abdulla S, Kobeleva X, Körner S, Petri S, Meyer T Tags: Nervenarzt Source Type: research